Registration is still open. (Even if it’s virtual) for the upcoming CAN.HEAL Stakeholder Conference. which will take place on Wednesday April 26 and Thursday April 27 of this week. Seats are full And we cannot accept additional registrations to participate in person.
However, for colleagues who wish to track Stakeholder activity online, please email my colleague Marta Kozaric: [ป้องกันอีเมล].
please click Click here to read more details. to see the schedule and click Click here to read more details. For the CAN.HEAL website
To match perfectly with the imperfect moments we encounter. This meeting therefore gives the right “Reducing inequality across the EU”The event is organized by the European Cancer Patient Coalition and EAPM.
The key function of the CAN.HEAL Conference is to bring experts together to agree policies through consensus. and present our conclusions to policy makers. and this time We have moved further into an area of expertise. In the midst of the great crisis we are all facing.
So what are the topics on the table?
The need to tackle cancer is clear – and the EU Beating Cancer Plan initiative can certainly lead to solutions. With more than €4 billion in funding and pathways to further funding through EU projects on research and regional funding and regeneration.
There is no doubt about the scale and severity of the demand. Cancer is the second leading cause of death in the countries of the European Union after cardiovascular disease, with approximately 2.6 million people diagnosed each year and killing an additional 1.2 million people.
The total economic burden of cancer in Europe is estimated to be more than €100 billion per year. As well as putting pressure on individuals public health and the country’s social system and the state budget The disease also affected productivity and economic growth.
New scientific insights, new techniques and methods open new horizons for improving diagnosis and good care.
However, access is uneven. research needs and potential beyond current resources Clearly useful practices such as population-level lung cancer screening Not yet an overview And quality of life for patients and survivors is only just beginning. It deserves attention.
The EU can assist member states that wish to formulate evidence-based policies to ensure that all EU citizens can be protected. Cancer screening, diagnosis, treatment and care are equally high quality, but cancer is not the only disease. and different types of cancer present different challenges that should be taken into account in policy discussions.
In addition to its general actions that can help in the fight against cancer in general. It is also only needed in certain types of cancer.
This stakeholder meeting will look at specific issues in order to plan the way forward.
Part of this exercise includes considering the details of Europe and its constituent countries. The complexity of forward planning approaches is doubled by the diversity of national and regional approaches to cancer. local epidemiology and health disparities The system upon which improvement depends – particularly given the supply of resources and expertise for testing, treatment and reimbursement. or infrastructure and demand considerations for Acceptance and Recognition events
This dilemma provides a rationale for this stakeholder meeting by exploring the possibility of joint efforts to identify gaps and promote improvements in the field of cancer. paying particular attention to accessibility and diagnosis for all The same is true of public health genomes.
Now is the time to develop cooperation through the EU Beating Cancer Plan, Horizon Europe and other policy tools. the European Union in collaboration with member countries, regions and cities, as well as the Institute of civil society and industry
This can guarantee maximum benefit from the available resources. Regarding EU funding from Horizon Europe for research and development operations, use of other MFF instruments, national/regional financial support. and reduce the risk of private investment
Despite all the differences between cancer and resources and national and regional methods of cancer care, But there is one common objective of seeking wider and fairer access to the best treatment for all European citizens, but a major challenge that remains for cancer patients is access equal to Screening treatment and innovative treatment
In addition, most mechanisms to achieve this goal require as much national – or more so – EU action. The distribution of innovative medicines continues to take place at a national level.
Much of Europe’s work is to promote collaboration. Showcase best practices Promote improvements and leverage learning from the latest pandemic.
The above is just a sample of the big topics, including many for the conversation of the day. Don’t forget to join us on 26-27 April.
Again, if you want to join virtually Contact my colleague Marta Kozaric: [ป้องกันอีเมล]To join the virtual and click. Click here to read more details. to see the agenda
The event is organized by the European Cancer Patient Coalition and EAPM.
Share this article:
